Literature DB >> 33357455

Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis.

Yun Pyo Kang1, Andrea Mockabee-Macias1, Chang Jiang1, Aimee Falzone1, Nicolas Prieto-Farigua1, Everett Stone2, Isaac S Harris3, Gina M DeNicola4.   

Abstract

Cysteine is required for maintaining cellular redox homeostasis in both normal and transformed cells. Deprivation of cysteine induces the iron-dependent form of cell death known as ferroptosis; however, the metabolic consequences of cysteine starvation beyond impairment of glutathione synthesis are poorly characterized. Here, we find that cystine starvation of non-small-cell lung cancer cell lines induces an unexpected accumulation of γ-glutamyl-peptides, which are produced due to a non-canonical activity of glutamate-cysteine ligase catalytic subunit (GCLC). This activity is enriched in cell lines with high levels of NRF2, a key transcriptional regulator of GCLC, but is also inducible in healthy murine tissues following cysteine limitation. γ-glutamyl-peptide synthesis limits the accumulation of glutamate, thereby protecting against ferroptosis. These results indicate that GCLC has a glutathione-independent, non-canonical role in the protection against ferroptosis by maintaining glutamate homeostasis under cystine starvation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GCLC; NRF2; cysteine; cystine; ferroptosis; glutamate; γ-glutamyl

Mesh:

Substances:

Year:  2020        PMID: 33357455      PMCID: PMC7839835          DOI: 10.1016/j.cmet.2020.12.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   31.373


  76 in total

1.  Restoration of p53 function leads to tumour regression in vivo.

Authors:  Andrea Ventura; David G Kirsch; Margaret E McLaughlin; David A Tuveson; Jan Grimm; Laura Lintault; Jamie Newman; Elizabeth E Reczek; Ralph Weissleder; Tyler Jacks
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

2.  Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.

Authors:  Isaac S Harris; Aislinn E Treloar; Satoshi Inoue; Masato Sasaki; Chiara Gorrini; Kim Chung Lee; Ka Yi Yung; Dirk Brenner; Christiane B Knobbe-Thomsen; Maureen A Cox; Andrew Elia; Thorsten Berger; David W Cescon; Adewunmi Adeoye; Anne Brüstle; Sam D Molyneux; Jacqueline M Mason; Wanda Y Li; Kazuo Yamamoto; Andrew Wakeham; Hal K Berman; Rama Khokha; Susan J Done; Terrance J Kavanagh; Ching-Wan Lam; Tak W Mak
Journal:  Cancer Cell       Date:  2015-01-22       Impact factor: 31.743

3.  FSP1 is a glutathione-independent ferroptosis suppressor.

Authors:  Sebastian Doll; Florencio Porto Freitas; Ron Shah; Maceler Aldrovandi; Milene Costa da Silva; Irina Ingold; Andrea Goya Grocin; Thamara Nishida Xavier da Silva; Elena Panzilius; Christina H Scheel; André Mourão; Katalin Buday; Mami Sato; Jonas Wanninger; Thibaut Vignane; Vaishnavi Mohana; Markus Rehberg; Andrew Flatley; Aloys Schepers; Andreas Kurz; Daniel White; Markus Sauer; Michael Sattler; Edward William Tate; Werner Schmitz; Almut Schulze; Valerie O'Donnell; Bettina Proneth; Grzegorz M Popowicz; Derek A Pratt; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nature       Date:  2019-10-21       Impact factor: 49.962

4.  Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.

Authors:  K Furuyama; S Sassa
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 5.  The role of glutathione in cancer.

Authors:  Ganesaratnam K Balendiran; Rajesh Dabur; Deborah Fraser
Journal:  Cell Biochem Funct       Date:  2004 Nov-Dec       Impact factor: 3.685

6.  Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure.

Authors:  Ying Chen; Yi Yang; Marian L Miller; Dongxiao Shen; Howard G Shertzer; Keith F Stringer; Bin Wang; Scott N Schneider; Daniel W Nebert; Timothy P Dalton
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

7.  Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.

Authors:  Eric Habib; Katja Linher-Melville; Han-Xin Lin; Gurmit Singh
Journal:  Redox Biol       Date:  2015-03-18       Impact factor: 11.799

8.  The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.

Authors:  Chun-Shik Shin; Prashant Mishra; Jeramie D Watrous; Valerio Carelli; Marilena D'Aurelio; Mohit Jain; David C Chan
Journal:  Nat Commun       Date:  2017-04-21       Impact factor: 14.919

9.  Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.

Authors:  L Torrente; C Sanchez; R Moreno; S Chowdhry; P Cabello; K Isono; H Koseki; T Honda; J D Hayes; A T Dinkova-Kostova; L de la Vega
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

10.  The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.

Authors:  Kirill Bersuker; Joseph M Hendricks; Zhipeng Li; Leslie Magtanong; Breanna Ford; Peter H Tang; Melissa A Roberts; Bingqi Tong; Thomas J Maimone; Roberto Zoncu; Michael C Bassik; Daniel K Nomura; Scott J Dixon; James A Olzmann
Journal:  Nature       Date:  2019-10-21       Impact factor: 49.962

View more
  37 in total

Review 1.  Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.

Authors:  Brent R Stockwell
Journal:  Cell       Date:  2022-07-07       Impact factor: 66.850

2.  Differential regulation of cerebral microvascular transcription by single and repetitive hypoxic conditioning.

Authors:  Jarrod C Harman; David A Otohinoyi; John W Reitnauer; Ann M Stowe; Jeff M Gidday
Journal:  Cond Med       Date:  2021

Review 3.  The Role of Ferroptosis in Acute Kidney Injury.

Authors:  Jinshi Zhang; Binqi Wang; Shizhu Yuan; Qiang He; Juan Jin
Journal:  Front Mol Biosci       Date:  2022-06-30

4.  A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer.

Authors:  Chang Jiang; Nathan P Ward; Nicolas Prieto-Farigua; Yun Pyo Kang; Anish Thalakola; Mingxiang Teng; Gina M DeNicola
Journal:  Redox Biol       Date:  2022-06-02       Impact factor: 10.787

5.  Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11.

Authors:  Xinbo Wang; Yueqing Chen; Xudong Wang; Hongling Tian; Yanjin Wang; Jiali Jin; Zezhi Shan; Yu'e Liu; Zhenyu Cai; Xinyuan Tong; Yi Luan; Xiao Tan; Bing Luan; Xin Ge; Hongbin Ji; Xuejun Jiang; Ping Wang
Journal:  Cancer Res       Date:  2021-08-12       Impact factor: 12.701

6.  Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma.

Authors:  Olivier Delattre; Dimiter S Dimitrov; Hai-Feng Zhang; Christopher S Hughes; Wei Li; Jian-Zhong He; Didier Surdez; Amal M El-Naggar; Hongwei Cheng; Anna Prudova; Alberto Delaidelli; Gian Luca Negri; Xiaojun Li; Maj Sofie Ørum-Madsen; Michael M Lizardo; Htoo Zarni Oo; Shane Colborne; Taras Shyp; Renata Scopim-Ribeiro; Colin A Hammond; Anne-Chloe Dhez; Sofya Langman; Jonathan K M Lim; Sonia H Y Kung; Amy Li; Anne Steino; Mads Daugaard; Seth J Parker; Ramon I Klein Geltink; Rimas J Orentas; Li-Yan Xu; Gregg B Morin; Poul H Sorensen
Journal:  Cancer Discov       Date:  2021-05-21       Impact factor: 39.397

7.  Ferroptosis in infection, inflammation, and immunity.

Authors:  Xin Chen; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  J Exp Med       Date:  2021-05-12       Impact factor: 14.307

Review 8.  The role of ROS in tumour development and progression.

Authors:  Eric C Cheung; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2022-01-31       Impact factor: 60.716

9.  Effects of acute iron overload on Nrf2-related glutathione metabolism in rat brain.

Authors:  Natacha E Piloni; Romina Vargas; Virginia Fernández; Luis A Videla; Susana Puntarulo
Journal:  Biometals       Date:  2021-06-16       Impact factor: 2.949

10.  Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung Cancer.

Authors:  Taisheng Liu; Honglian Luo; Jinye Zhang; Xiaoshan Hu; Jian Zhang
Journal:  BMC Cancer       Date:  2021-07-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.